{"id":"norepinephrine-vasopressin","safety":{"commonSideEffects":[{"rate":null,"effect":"Tachycardia"},{"rate":null,"effect":"Arrhythmias"},{"rate":null,"effect":"Tissue ischemia/necrosis at infusion site"},{"rate":null,"effect":"Hypertension"},{"rate":null,"effect":"Decreased urine output"}]},"_chembl":{"chemblId":"CHEMBL432","moleculeType":"Small molecule","molecularWeight":"169.18"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Norepinephrine is a catecholamine that binds alpha-1 and beta-1 adrenergic receptors to increase vasoconstriction and cardiac contractility. Vasopressin (antidiuretic hormone) activates V1 receptors on vascular smooth muscle to cause vasoconstriction and improve blood pressure. Together, they provide synergistic hemodynamic support in shock states by restoring vascular tone and perfusion pressure.","oneSentence":"This combination of norepinephrine and vasopressin acts as a dual vasopressor agent that increases blood pressure and tissue perfusion through alpha-adrenergic stimulation and vasopressin V1 receptor activation.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-27T23:57:35.865Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Septic shock refractory to fluid resuscitation"},{"name":"Cardiogenic shock"},{"name":"Hypotensive states in critical care settings"}]},"trialDetails":[{"nctId":"NCT06709573","phase":"PHASE4","title":"Early Versus Late Adjunctive Vasopressin in Septic Shock","status":"RECRUITING","sponsor":"The Cleveland Clinic","startDate":"2025-04-29","conditions":"Sepsis, Septic Shock","enrollment":300},{"nctId":"NCT06426407","phase":"","title":"Vasopressin Hemodynamic Response as a Septic Shock Subphenotype Indicator","status":"TERMINATED","sponsor":"The Cleveland Clinic","startDate":"2025-10-01","conditions":"Shock, Septic","enrollment":2},{"nctId":"NCT06344442","phase":"PHASE3","title":"Low-dose Arginine-vasopressin Supplementation on Post-transplant Acute Kidney Injury After Liver Transplantation (AVENIR Trial)","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2025-04-16","conditions":"Acute Kidney Injury Post Liver Transplantation","enrollment":304},{"nctId":"NCT05824767","phase":"PHASE4","title":"Serum Biomarkers to Predict Response to Angiotensin II in Septic Shock","status":"COMPLETED","sponsor":"University of New Mexico","startDate":"2023-04-17","conditions":"Septic Shock, Vasodilatory Shock","enrollment":40},{"nctId":"NCT06464510","phase":"PHASE3","title":"Norepinephrine and Vasopressin for Rescue Versus Early Vasopressin for Vasopressor Dependent Sepsis","status":"RECRUITING","sponsor":"Hospital do Coracao","startDate":"2024-11-21","conditions":"Septic Shock","enrollment":2800},{"nctId":"NCT07063680","phase":"PHASE3","title":"Efficacy of Early Argipressin in the Management of Intensive Care Patients With Norepinephrine-refractory Vasoplegic Shock","status":"NOT_YET_RECRUITING","sponsor":"Centre Hospitalier Universitaire Dijon","startDate":"2026-01","conditions":"Patients With Norepinephrine-refractory Vasoplegic Shock","enrollment":390},{"nctId":"NCT02118467","phase":"PHASE4","title":"Vasoactive Drugs in Intensive Care Unit","status":"RECRUITING","sponsor":"University of Chicago","startDate":"2014-05-15","conditions":"Shock","enrollment":836},{"nctId":"NCT05568160","phase":"PHASE3","title":"Evaluation of the Superiority of VAsopressin Versus NOradrenaline in the Management of Patients at Risk of Kidney Failure Undergoing Cardiac Surgery With Extracorporeal Circulation","status":"ACTIVE_NOT_RECRUITING","sponsor":"Centre Hospitalier Universitaire Dijon","startDate":"2023-01-02","conditions":"Scheduled Cardiac Surgery With Extracorporeal Circulation, Vasoplegic Syndrome","enrollment":840},{"nctId":"NCT07286643","phase":"NA","title":"Echocardiography-guided Cirrhosis and Liver Failure-Intensive Care Protocol Sepsis","status":"RECRUITING","sponsor":"Post Graduate Institute of Medical Education and Research, Chandigarh","startDate":"2026-01-01","conditions":"Cirrhosis, Liver, Cirrhotic Cardiomyopathy, Septic Shock","enrollment":140},{"nctId":"NCT07255378","phase":"","title":"Use of Vassopresin in Septic Shock Prospective Multicenter Observational Study With Medication","status":"RECRUITING","sponsor":"Jamil Cedeño Mora","startDate":"2025-10-01","conditions":"Septic Shock","enrollment":1200},{"nctId":"NCT06217562","phase":"PHASE4","title":"Vasopressin for Septic Shock Pragmatic Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"Intermountain Health Care, Inc.","startDate":"2024-02-01","conditions":"Septic Shock","enrollment":2050},{"nctId":"NCT04592744","phase":"PHASE4","title":"Angiotensin 2 for AKI After OLT","status":"ENROLLING_BY_INVITATION","sponsor":"University of California, Los Angeles","startDate":"2022-04-08","conditions":"Cirrhosis, Liver, End Stage Liver DIsease, Acute Kidney Injury","enrollment":30},{"nctId":"NCT06155812","phase":"PHASE2, PHASE3","title":"Multimodal Vasopressor Strategy in Septic Shock","status":"RECRUITING","sponsor":"University Medical Centre Maribor","startDate":"2023-12-23","conditions":"Shock, Septic","enrollment":80},{"nctId":"NCT04682483","phase":"","title":"Cardiogenic Shock Working Group Registry","status":"RECRUITING","sponsor":"Tufts Medical Center","startDate":"2017-12-04","conditions":"Cardiogenic Shock","enrollment":5000},{"nctId":"NCT06953297","phase":"","title":"Vasopressin Use in Septic Shock From Türkiye","status":"COMPLETED","sponsor":"Karadeniz Technical University","startDate":"2024-01-01","conditions":"Septic Shock, Vasodilatory Shock, Critical Illness Sepsis, Severe","enrollment":146},{"nctId":"NCT06934798","phase":"PHASE4","title":"Inotropic Effects of Vasopressin Versus Noradrenaline In Patients With Vasoplegic Syndrome After Cardiac Surgery","status":"RECRUITING","sponsor":"University of Sao Paulo","startDate":"2024-04-01","conditions":"Vasoplegic Syndrome of Cardiac Surgery","enrollment":350},{"nctId":"NCT06234592","phase":"NA","title":"The Effect of Vasopressor Therapy on Renal Perfusion in Septic Shock","status":"RECRUITING","sponsor":"King's College Hospital NHS Trust","startDate":"2024-01-05","conditions":"Septic Shock, Acute Kidney Injury","enrollment":45},{"nctId":"NCT04501861","phase":"PHASE3","title":"Hemodynamic Effect of Norepinephrine Versus Vasopressin on the Pulmonary Circulation in Cardiac Surgery Patients:","status":"COMPLETED","sponsor":"The Cleveland Clinic","startDate":"2020-11-05","conditions":"Cardiac Disease","enrollment":153},{"nctId":"NCT05506319","phase":"PHASE4","title":"Hypotension in the Weaning From Vasopressor Drugs","status":"COMPLETED","sponsor":"Hospital Nossa Senhora da Conceicao","startDate":"2022-05-01","conditions":"Septic Shock","enrollment":78},{"nctId":"NCT06853574","phase":"NA","title":"Ventriculo-arterial Coupling and Myocardial Work in Sepsis and Septic Shock","status":"NOT_YET_RECRUITING","sponsor":"General and Teaching Hospital Celje","startDate":"2025-02","conditions":"Sepsis, Septic Shock","enrollment":30},{"nctId":"NCT05346393","phase":"NA","title":"HRS-AKI Treatment With TIPS in Patients With Cirrhosis","status":"RECRUITING","sponsor":"Jena University Hospital","startDate":"2022-11-29","conditions":"Cirrhosis, Liver, Hepatorenal Syndrome, Acute Kidney Injury","enrollment":124},{"nctId":"NCT06556472","phase":"NA","title":"Safety and Efficacy of Continuous Infusion of Terlipressin With Norepinephrine Versus Norepinephrine Alone in Improving Outcomes of Acute Kidney Injury in Acute on Chronic Liver Failure With Septic Shock","status":"NOT_YET_RECRUITING","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2024-08-15","conditions":"Acute on Chronic Liver Failure","enrollment":126},{"nctId":"NCT06499467","phase":"","title":"Norepinephrine Equivalent Dose of Vasopressin, Phenylephrine and Epinephrine in Septic Shock","status":"RECRUITING","sponsor":"Sanjay Gandhi Postgraduate Institute of Medical Sciences","startDate":"2024-07-12","conditions":"Septic Shock","enrollment":100},{"nctId":"NCT06471231","phase":"PHASE4","title":"Renal Outcomes in the Early Use of Vasopressin in the Treatment of Septic Shock","status":"RECRUITING","sponsor":"Azienda Usl di Bologna","startDate":"2024-05-15","conditions":"Septic Shock, Renal Function Replacement","enrollment":264},{"nctId":"NCT06376318","phase":"","title":"Shock and Acute Conditions OutcOmes Platform","status":"ACTIVE_NOT_RECRUITING","sponsor":"Saint-Louis Hospital, Paris, France","startDate":"2024-01-01","conditions":"Circulatory Shock, Sepsis, Cardiogenic Shock","enrollment":1000},{"nctId":"NCT05193370","phase":"PHASE4","title":"Angiotensin II vs. Vasopressin in Septic Shock","status":"WITHDRAWN","sponsor":"University of New Mexico","startDate":"2022-01-03","conditions":"Septic Shock","enrollment":""},{"nctId":"NCT04053478","phase":"NA","title":"Effects of Ephedrine, Phenylephrine, Norepinephrine and Vasopressin on Contractility of Human Myometrium and Umbilical Vessels: An In-vitro Study","status":"RECRUITING","sponsor":"Samuel Lunenfeld Research Institute, Mount Sinai Hospital","startDate":"2019-07-08","conditions":"Hypotension","enrollment":144},{"nctId":"NCT06265259","phase":"PHASE4","title":"Efficacy of the Use of Vasopressin as a Primary Vasoconstrictor in Critically Ill Patients","status":"RECRUITING","sponsor":"University of Thessaly","startDate":"2023-12-15","conditions":"Circulatory Shock","enrollment":145},{"nctId":"NCT05774067","phase":"NA","title":"Noradrenaline Versus Glypressin for Prevention of Hypotension After Deflation of Tourniquet in Knee Arthroplasty","status":"COMPLETED","sponsor":"Tanta University","startDate":"2022-12-01","conditions":"Norepinephrine, Glypressin, Tourniquet Deflation, Hypotension","enrollment":135},{"nctId":"NCT06125184","phase":"NA","title":"Effect of Vasopressin on Kidney and Cardiac Function in Septic Shock","status":"UNKNOWN","sponsor":"Pontificia Universidad Catolica de Chile","startDate":"2022-11-01","conditions":"Kidney Injury, Acute, Cardiac Function Failed","enrollment":50},{"nctId":"NCT03483753","phase":"PHASE2, PHASE3","title":"Vasopressin or Norepinephrine in Vasoplegic Shock After Non-cardiac Surgery","status":"WITHDRAWN","sponsor":"University of Sao Paulo","startDate":"2019-01","conditions":"Circulatory Shock, Non-cardiac Surgery","enrollment":""},{"nctId":"NCT06055907","phase":"","title":"Influence of Vasopressors on Anti-Xa Activity in Critically Ill Patients","status":"UNKNOWN","sponsor":"Medical University of Gdansk","startDate":"2023-05-15","conditions":"Critical Illness, Thrombosis","enrollment":50},{"nctId":"NCT05389813","phase":"PHASE2, PHASE3","title":"Comparison Between Oxycodone and Pregabalin as Preemptive Analgesia","status":"UNKNOWN","sponsor":"An-Najah National University","startDate":"2021-08-15","conditions":"Anesthesia","enrollment":150},{"nctId":"NCT05886192","phase":"PHASE4","title":"The Construction and Application of Therapeutic System of Intelligent Decision-Oriented Hemodynamic Organized Therapy for Shock Patients","status":"UNKNOWN","sponsor":"Peking Union Medical College Hospital","startDate":"2023-05-01","conditions":"Septic Shock","enrollment":60},{"nctId":"NCT03822091","phase":"PHASE3","title":"Terlipressin Infusion Alone Vs Terlipressin With Noradrenaline Infusion In The Treatment of Hepatorenal Syndrome Type 1","status":"COMPLETED","sponsor":"Post Graduate Institute of Medical Education and Research, Chandigarh","startDate":"2019-01-28","conditions":"Type 1 HEPATO RENAL SYNDROME(HRS)","enrollment":60},{"nctId":"NCT05207280","phase":"PHASE3","title":"Clinical Trial Comparing Noradrenaline (NA) Plus Placebo Versus Noradrenaline Plus Terlipressin (TP) in Septic Shock","status":"UNKNOWN","sponsor":"Fundación Pública Andaluza para la gestión de la Investigación en Sevilla","startDate":"2022-10-11","conditions":"Septic Shock","enrollment":152},{"nctId":"NCT05674084","phase":"","title":"Vasopressor Support, Mean Arterial Pressure and Capillary Refill Time in Critically Ill Patients","status":"UNKNOWN","sponsor":"Medical University of Silesia","startDate":"2022-12-03","conditions":"Critical Illness","enrollment":150},{"nctId":"NCT04089072","phase":"PHASE2","title":"Methylene Blue as a Third-line Vasopressor in Septic Shock","status":"UNKNOWN","sponsor":"Carilion Clinic","startDate":"2019-12-01","conditions":"Septic Shock","enrollment":250},{"nctId":"NCT04214145","phase":"NA","title":"The Effect of Vasopressors on Cerebral Oxygentaion During Off Pump CABG","status":"COMPLETED","sponsor":"Seoul National University Hospital","startDate":"2020-01-07","conditions":"Cerebral Oxygen Saturation","enrollment":90},{"nctId":"NCT04339868","phase":"PHASE2","title":"Terlipressin for Refractory Septic Shock","status":"UNKNOWN","sponsor":"Mahidol University","startDate":"2020-04-03","conditions":"Septic Shock, Refractory Shock, Norepinephrine Adverse Reaction","enrollment":130},{"nctId":"NCT04991259","phase":"NA","title":"To Evaluate the Safety and Efficacy of Preemptive Administration of Continuous Renal Replacement Therapy in Patients With Acute Liver Failure With Cerebral Edema","status":"UNKNOWN","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2021-08-10","conditions":"Acute Liver Failure","enrollment":60},{"nctId":"NCT04170751","phase":"NA","title":"Effect of Vasopressin vs Norepinephrine on Pulmonary Oxygenation and Lung Mechanics in Patients With Hypertension Therapy During One-lung Ventilation : Preliminary Study","status":"UNKNOWN","sponsor":"Yonsei University","startDate":"2019-11-18","conditions":"Hypertension","enrollment":40},{"nctId":"NCT02330432","phase":"PHASE2, PHASE3","title":"Mycobacterium w in Patients With Severe Sepsis","status":"COMPLETED","sponsor":"Post Graduate Institute of Medical Education and Research, Chandigarh","startDate":"2016-01","conditions":"Sepsis","enrollment":202},{"nctId":"NCT04586790","phase":"PHASE2","title":"the Effect of Oral Vasopressors for Liberation From IV Vasopressors in Spinal Shock","status":"UNKNOWN","sponsor":"Ahmed talaat ahmed aly","startDate":"2020-10-15","conditions":"Spinal Shock","enrollment":90},{"nctId":"NCT04302584","phase":"NA","title":"Norepinephrine / Vasopressin Combination for Resuscitation in Septic Shock","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2018-01-01","conditions":"Septic Shock, Acute Kidney Injury","enrollment":90},{"nctId":"NCT04014010","phase":"","title":"Machine Learning Modeling of Intraoperative Hemodynamic Predictors of Postoperative Outcomes","status":"COMPLETED","sponsor":"Janny Xue Chen Ke","startDate":"2013-01-01","conditions":"Perioperative/Postoperative Complications, Morbidity, Multiple, Surgery","enrollment":35000},{"nctId":"NCT02718079","phase":"NA","title":"High-Volume Plasma Exchange Versus Standard Medical Treatment in Patients With Acute Liver Failure","status":"COMPLETED","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2016-12-30","conditions":"Acute Liver Failure","enrollment":40},{"nctId":"NCT00624650","phase":"PHASE2","title":"Hemodynamics and Extravascular Lung Water in Acute Lung Injury","status":"COMPLETED","sponsor":"Oregon Health and Science University","startDate":"2008-02","conditions":"Acute Lung Injury","enrollment":33},{"nctId":"NCT02726620","phase":"NA","title":"Decision Support for Intraoperative Low Blood Pressure","status":"COMPLETED","sponsor":"Vanderbilt University Medical Center","startDate":"2017-01-05","conditions":"Hypotension","enrollment":22435},{"nctId":"NCT01800877","phase":"NA","title":"Optimal VAsopressor titraTION Pilot Randomized Controlled Trial","status":"COMPLETED","sponsor":"Francois Lamontagne","startDate":"2013-04","conditions":"Hypotension, Shock","enrollment":120},{"nctId":"NCT03014063","phase":"","title":"Vasopressin Plasma Concentrations in Patients Receiving Exogenous Vasopressin Infusion for Septic Shock","status":"COMPLETED","sponsor":"The Cleveland Clinic","startDate":"2016-11","conditions":"Septic Shock","enrollment":18},{"nctId":"NCT03336814","phase":"PHASE4","title":"Evaluation of Early Association of Terlipressin and Norepinephrine During Septic Shock; the TerliNor Study","status":"UNKNOWN","sponsor":"Assistance Publique Hopitaux De Marseille","startDate":"2018-07-27","conditions":"Septic Shock","enrollment":40},{"nctId":"NCT01718613","phase":"PHASE3","title":"Vasopressin Versus Norepinephrine for the Management of Septic Shock in Cancer Patients","status":"COMPLETED","sponsor":"Instituto do Cancer do Estado de São Paulo","startDate":"2012-11","conditions":"Septic Shock","enrollment":250},{"nctId":"NCT02454348","phase":"PHASE4","title":"NOrepinephrine and VasoprEssin Versus Norepinephrine aLone in Critically Ill Patients With Septic Shock","status":"WITHDRAWN","sponsor":"University of Arkansas","startDate":"2015-11-01","conditions":"Shock, Septic","enrollment":""},{"nctId":"NCT02573727","phase":"NA","title":"To Compare the Response Rate of Noradrenaline vs. Terlipressin in Hepatorenal Syndrome in Patients With Acute on Chronic Liver Failure","status":"COMPLETED","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2015-10","conditions":"Acute on Chronic Liver Failure","enrollment":120},{"nctId":"NCT02468063","phase":"NA","title":"To Assess the Efficacy of Early Introduction of a Combination of Low Dose Vasopressin Analogue in Addition to Noradrenaline as a Vasopressor in Patients of Cirrhosis With Septic Shock","status":"COMPLETED","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2015-05-01","conditions":"Cirrhosis With Septic Shock","enrollment":184},{"nctId":"NCT03288610","phase":"","title":"Prediction of Inflammatory Response and Hypotensive Syndrome After Cardiac Surgery by Preoperative Copeptin Level","status":"COMPLETED","sponsor":"University Hospital, Montpellier","startDate":"2017-01","conditions":"Systemic Inflammatory Response Syndrome (SIRS), Postoperative Vasodilation Syndrome, Stress Response","enrollment":200},{"nctId":"NCT01836224","phase":"NA","title":"Efficacy and Safety of Monotherapy With Noradrenaline and Terlipressin in Patients of Cirrhosis With Septic Shock Admitted to Intensive Care Unit","status":"COMPLETED","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2012-10","conditions":"Cirrhosis With Septic Shock","enrollment":84},{"nctId":"NCT02675868","phase":"PHASE4","title":"Effects of Vasopressors on Immune Response","status":"COMPLETED","sponsor":"Radboud University Medical Center","startDate":"2016-01","conditions":"Endotoxemia","enrollment":40},{"nctId":"NCT01649037","phase":"NA","title":"To Compare the Efficacy of Nor Adrenaline and Terlipressin vs Step up Terlipressin Therapy in Hepatorenal Syndrome","status":"WITHDRAWN","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2012-08","conditions":"Hepatorenal Syndrome","enrollment":""},{"nctId":"NCT00628160","phase":"PHASE2, PHASE3","title":"Terlipressin in Septic Shock in Cirrhosis","status":"COMPLETED","sponsor":"Hospital Clinic of Barcelona","startDate":"2006-10","conditions":"Liver Cirrhosis, Septic Shock","enrollment":72},{"nctId":"NCT01493102","phase":"NA","title":"Discontinuation Order of Vasopressors in Septic Shock","status":"TERMINATED","sponsor":"Samsung Medical Center","startDate":"2011-12","conditions":"Septic Shock","enrollment":78},{"nctId":"NCT02306239","phase":"NA","title":"The Effect of Terlipressin on Intesitnal Function in Septic Shock Patients","status":"UNKNOWN","sponsor":"Liu ZiMeng","startDate":"2014-12","conditions":"Terlipressin, Septic Shock","enrollment":40},{"nctId":"NCT01697410","phase":"NA","title":"Continuos Terlipressin Infusion in Septic Shock","status":"UNKNOWN","sponsor":"First Affiliated Hospital, Sun Yat-Sen University","startDate":"2013-01","conditions":"Septic Shock","enrollment":1000},{"nctId":"NCT00795366","phase":"NA","title":"Vasopressin Versus Catecholamines for Cerebral Perfusion Pressure Control in Brain Injured Trauma Patients","status":"COMPLETED","sponsor":"University of Miami","startDate":"2008-09","conditions":"Traumatic Brain Injury","enrollment":96},{"nctId":"NCT01271114","phase":"PHASE3","title":"Hypertonic Saline and Terlipressin for Sepsis-associated Hypotension","status":"TERMINATED","sponsor":"Hospital General de Ciudad Real","startDate":"2012-06","conditions":"Septic Shock, Sepsis-associated Hypotension","enrollment":21},{"nctId":"NCT01505231","phase":"PHASE3","title":"Vasopressin Versus Norepinephrine for the Management of Shock After Cardiac Surgery","status":"UNKNOWN","sponsor":"University of Sao Paulo","startDate":"2012-01","conditions":"Shock","enrollment":300},{"nctId":"NCT01637454","phase":"PHASE3","title":"TYPE 2 HEPATORENAL SYNDROME","status":"COMPLETED","sponsor":"Post Graduate Institute of Medical Education and Research, Chandigarh","startDate":"2009-01","conditions":"Safety and Efficacy of Terlipressin and Noradrenaline and Predictive Factors of Response in Type 2 HRS","enrollment":46},{"nctId":"NCT00995839","phase":"PHASE2, PHASE3","title":"Terlipressin in Septic Shock: Effects on Microcirculation","status":"COMPLETED","sponsor":"University of Roma La Sapienza","startDate":"2008-11","conditions":"Septic Shock, Sepsis","enrollment":60},{"nctId":"NCT00481572","phase":"PHASE2","title":"Continuous Infusion of Terlipressin in Septic Shock","status":"COMPLETED","sponsor":"University of Roma La Sapienza","startDate":"2007-01","conditions":"Septic Shock","enrollment":45}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":89,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"norepinephrine+vasopressin","genericName":"norepinephrine+vasopressin","companyName":"Peking Union Medical College Hospital","companyId":"peking-union-medical-college-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Norepinephrine and vasopressin are small molecule interventions used to treat conditions such as septic shock, vasodilatory shock, sepsis, and shock.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}